Beth Israel Deaconess Medical Center, Inc.;Georgia State University Research Foundation, Inc.
发明人:
申请号:
EP10739160.9
公开号:
EP2393420B1
申请日:
2010.02.05
申请国别(地区):
EP
年份:
2018
代理人:
摘要:
The present invention relates to compositions and methods of optically imaging tissues or cells using imaging agents have in vivo properties that result in signal-to-background ratios of at least about 1:1. TL is a targeting ligand and n is −1, 0 or +1.